Jun 30, 2011

Neurocrine Biosciences Q2 2011 Earnings Report

Total Revenue
$12.2M
Previous year: $5.4M
+125.3%
EPS
$0.04
Previous year: -$0.27
-114.8%
Gross Profit
$12.2M
Previous year: $4.64M
+161.8%
Cash and Equivalents
$18.8M
Previous year: $95.1M
-80.2%
Free Cash Flow
-$6.04M
Previous year: $53.1M
-111.4%
Total Assets
$127M

Neurocrine Biosciences

Neurocrine Biosciences